15q11.2 BP1-BP2 copy number variants involving NIPA1, NIPA2, CYFIP1, and TUBGCP5 genes may not warrant a clinical outcome because of the phenotypic variability and low penetrance. The study aims to provide a greater understanding of the phenotypic diversity associated with these copy number variants. We conducted a retrospective analysis of 37 pediatric patients with deletions or duplications in 15q11.2 BP1-BP2 region, and compared the results systemically with the previous literature. Of the 37 patients, 67.6% had microduplications and 32.4% had microdeletions. The mean copy number variant size was 482 ± 157 kb. Patients had a variety of phenotypes including neurodevelopmental delay, hypotonia, speech impairment, intellectual and learning disability, behavioral and psychiatric symptoms, epilepsy and seizures, neuroimaging abnormalities, and dysmorphism. These findings, in combination with previous reports, confirm that copy number variants in this region are linked to phenotypes ranging from normal to severe neurodevelopmental and neuropsychiatric features. Our data also confirm that microcephaly is a particularly prevalent phenotype in patients with microdeletions, rather than in those with microduplications.
GillentineMASchaafCP. The human clinical phenotypes of altered CHRNA7 copy number. Biochem Pharmacol. 2015;97(4):352–362.
2.
PavonePRuggieriMMarinoSD, et al.Chromosome 15q BP3 to BP5 deletion is a likely locus for speech delay and language impairment: report on a four-member family and an unrelated boy. Mol Genet Genomic Med. 2020;8(4):e1109.
3.
ChamberlainSJLalandeM. Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11-q13. Neurobiol Dis. 2010;39(1):13–20.
4.
ButlerMGBittelDCKibiryevaNTalebizadehZThompsonT. Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics. 2004;113(3 Pt 1):565–573.
5.
BurnsideRDPasionRMikhailFM, et al.Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet. 2011;130(4):517–528.
6.
PicinelliCLintasCPirasIS, et al.Recurrent 15q11.2 BP1-BP2 microdeletions and microduplications in the etiology of neurodevelopmental disorders. Am J Med Genet B Neuropsychiatr Genet. 2016;171(8):1088–1098.
7.
GoytainAHinesRMEl-HusseiniAQuammeGA. NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter. J Biol Chem. 2007;282(11):8060–8068.
8.
SvenstrupKMøllerRSChristensenJBudtz-JørgensenEGillingMNielsenJE. NIPA1mutation in complex hereditary spastic paraplegia with epilepsy. Eur J Neurol. 2011;18(9):1197–1199.
9.
TantiMCairnsDMirzaNMcCannEYoungC. Is NIPA1-associated hereditary spastic paraplegia always ‘pure'? Further evidence of motor neuron disease and epilepsy as rare manifestations. Neurogenetics. 2020;21(4):305–308.
10.
JiangYZhangYZhangP, et al.NIPA2located in 15q11.2 is mutated in patients with childhood absence epilepsy. Hum Genet. 2012;131(7):1217–1224.
11.
NowickiSTTassoneFOnoMY, et al.The Prader-Willi phenotype of fragile X syndrome. J Dev Behav Pediatr. 2007;28(2):133–138.
12.
De WolfVBrisonNDevriendtKPeetersH. Genetic counseling for susceptibility loci and neurodevelopmental disorders: the del15q11.2 as an example. Am J Med Genet A. 2013;161A(11):2846–2854.
13.
AbdelmoityATLePichonJBNypSSSodenSEDanielCAYuS. 15q11.2 proximal imbalances associated with a diverse array of neuropsychiatric disorders and mild dysmorphic features. J Dev Behav Pediatr. 2012;33(7):570–576.
14.
DoornbosMSikkema-RaddatzBRuijvenkampCA, et al.Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances. Eur J Med Genet. 2009;52(2-3):108–115.
15.
MurthySKNygrenAOEl ShakankiryHM, et al.Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet Genome Res. 2007;116(1-2):135–140.
16.
van der ZwaagBStaalWGHochstenbachR, et al.A co-segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(4):960–966.
17.
VanlerbergheCPetitFMalanV, et al.15q11.2 Microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patients. Eur J Med Genet. 2015;58(3):140–147.
18.
von der LippeCRustadCHeimdalKRødningenOK. 15q11.2 microdeletion - seven new patients with delayed development and/or behavioural problems. Eur J Med Genet. 2011;54(3):357–360.
19.
Benítez-BurracoABarcos-MartínezMEspejo-PorteroIJiménez-RomeroS. Variable penetrance of the 15q11.2 BP1-BP2 microduplication in a family with cognitive and language impairment. Mol Syndromol. 2017;8(3):139–147.
20.
ChangXQuHLiuY, et al.Microduplications at the 15q11.2 BP1-BP2 locus are enriched in patients with anorexia nervosa. J Psychiatr Res. 2019;113:34–38.
21.
MohanKNCaoYPhamJ, et al.Phenotypic association of 15q11.2 CNVs of the region of breakpoints 1-2 (BP1-BP2) in a large cohort of samples referred for genetic diagnosis. J Hum Genet. 2019;64(3):253–255.
22.
UlfarssonMOWaltersGBGustafssonO, et al.15q11.2 CNV affects cognitive, structural and functional correlates of dyslexia and dyscalculia. Transl Psychiatry. 2017;7(4):e1109.
23.
BirnbaumRMahjaniBLoosRJFSharpAJ. Clinical characterization of copy number variants associated with neurodevelopmental disorders in a large-scale multiancestry biobank. JAMA Psychiatry. 2022;79(3):250–259.
24.
DasDKTapiasVD'AiutoL, et al.Genetic and morphological features of human iPSC-derived neurons with chromosome 15q11.2 (BP1-BP2) deletions. Mol Neuropsychiatry. 2015;1(2):116–123.
25.
HaanNWestacottLJCarterJ, et al.Haploinsufficiency of the schizophrenia and autism risk gene Cyfip1 causes abnormal postnatal hippocampal neurogenesis through microglial and Arp2/3 mediated actin dependent mechanisms. Transl Psychiatry. 2021;11(1):313.
26.
PérezASTrivesIMAzorínIPMásLALledóEPSánchezFG. Microdeleción 15q11. 2 (BP1-BP2) un nuevo síndrome con expresividad variable. In Spanish. An Pediatr (Barc). 2011;75(1):58–62.
27.
MadrigalIRodríguez-RevengaLXunclàMMilàM. 15q11.2 microdeletion and FMR1 premutation in a family with intellectual disabilities and autism. Gene. 2012;508(1):92–95.
28.
WongDJohnsonSMYoungDIwamotoLSoodSSlavinTP. Expanding the BP1-BP2 15q11.2 microdeletion phenotype: tracheoesophageal fistula and congenital cataracts. Case Rep Genet. 2013;2013:801094.
29.
UsreyKMWilliamsCADasoukiMFairbrotherLCButlerMG. Congenital arthrogryposis: an extension of the 15q11.2 BP1-BP2 microdeletion syndrome?Case Rep Genet. 2014;2014:127258.
30.
CafferkeyMAhnJWFlinterFOgilvieC. Phenotypic features in patients with 15q11.2 (BP1-BP2) deletion: further delineation of an emerging syndrome. Am J Med Genet A. 2014;164A(8):1916–1922.
31.
ChenCPLinSPLeeCL, et al.Familial transmission of recurrent 15q11.2 (BP1-BP2) microdeletion encompassing NIPA1, NIPA2, CYFIP1, and TUBGCP5 associated with phenotypic variability in developmental, speech, and motor delay. Taiwan J Obstet Gynecol. 2017;56(1):93–97.
32.
ChowdhuryWPatakPChowdhuryFJ, et al.A rare case of 15q11.2 microdeletion syndrome with atypical features: diagnostic dilemma. Cureus. 2018;10(11):e3543.
33.
JønchAEDouardEMoreauC, et al.Estimating the effect size of the 15Q11.2 BP1-BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice. J Med Genet. 2019;56(10):701–710.
34.
ChuFCShawSWLeeCHLoLMHsuJJHungTH. Adverse perinatal and early life outcomes following 15q11.2 CNV diagnosis. Genes (Basel). 2021;12(10):1480.
35.
HanJYParkJ. Phenotypic diversity of 15q11.2 BP1-BP2 deletion in three Korean families with development delay and/or intellectual disability: a case series and literature review. Diagnostics (Basel). 2021;11(4):722.
36.
DemirciAKartalM. The prevalence of developmental delay among children aged 3-60 months in Izmir, Turkey. Child Care Health Dev. 2016;42(2):213–219.
37.
McKenzieKMiltonMSmithGOuellette-KuntzH. Systematic review of the prevalence and incidence of intellectual disabilities: current trends and issues. Curr Dev Disord Rep. 2016;3(2):104–115.
38.
WilliamsSGNakevAGuoH, et al.Association of congenital cardiovascular malformation and neuropsychiatric phenotypes with 15q11.2 (BP1-BP2) deletion in the UK biobank. Eur J Hum Genet. 2020;28(9):1265–1273.
39.
ZhangYZhouBZhangXXuQXuX. A 15q11.2 microdeletion first identified in a pair of autistic monozygotic twins with regression. Psychiatr Genet. 2015;25(1):43–44.
40.
FortinOVinceletteCChénierS, et al.Copy number variation in genetic epilepsy with febrile seizures plus. Eur J Paediatr Neurol. 2020;27:111–115.
41.
de KovelCGTrucksHHelbigI, et al.Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain. 2010;133(Pt 1):23–32.
42.
SilvaAIUlfarssonMOStefanssonH, et al.Reciprocal white matter changes associated with copy number variation at 15q11.2 BP1-BP2: a diffusion tensor imaging study. Biol Psychiatry. 2019;85(7):563–572.
43.
RadleyJAVasudevanPC. Is 15q11.2 microdeletion associated with periventricular nodular heterotopia?Clin Dysmorphol. 2015;24(4):156–158.
44.
Van Der MeerDSønderbyIEKaufmannT, et al.Association of copy number variation of the 15q11. 2 BP1-BP2 region with cortical and subcortical morphology and cognition. JAMA Psychiatry. 2020;77(4):420–430.
45.
MaverAČuturiloGKovandaAMiletićAPeterlinB. Rare missense TUBGCP5 gene variant in a patient with primary microcephaly. Eur J Med Genet. 2019;62(12):103598.
46.
KaurSRodriguezRPatelCDongJFangX. Late-onset unilateral peripheral neuropathy in a patient with chromosome 15q11.2 deletion. Neurology. 2017;88:P6–137.
47.
LiXShiGLiY, et al.15q11.2 deletion is enriched in patients with total anomalous pulmonary venous connection. J Med Genet. 2021;58(2):116–124.
48.
CamposCMZanardoEADutraRLKulikowskiLDKimCA. Investigation of copy number variation in children with conotruncal heart defects. Arq Bras Cardiol. 2015;104(1):24–31.
49.
StarkZBehrsinJBurgessT, et al.SNP microarray abnormalities in a cohort of 28 infants with congenital diaphragmatic hernia. Am J Med Genet A. 2015;167A(10):2319–2326.
50.
BarnekowEHasslowJLiuW, et al.A Swedish familial genome-wide haplotype analysis identified five novel breast cancer susceptibility loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31. Int J Mol Sci. 2023;24(5):4.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
